These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 18843023)

  • 21. High-resolution loss of heterozygosity screening implicates PTPRJ as a potential tumor suppressor gene that affects susceptibility to Non-Hodgkin's lymphoma.
    Aya-Bonilla C; Green MR; Camilleri E; Benton M; Keane C; Marlton P; Lea R; Gandhi MK; Griffiths LR
    Genes Chromosomes Cancer; 2013 May; 52(5):467-79. PubMed ID: 23341091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Haplotype-based analysis of genes associated with risk of adverse skin reactions after radiotherapy in breast cancer patients.
    Suga T; Ishikawa A; Kohda M; Otsuka Y; Yamada S; Yamamoto N; Shibamoto Y; Ogawa Y; Nomura K; Sho K; Omura M; Sekiguchi K; Kikuchi Y; Michikawa Y; Noda S; Sagara M; Ohashi J; Yoshinaga S; Mizoe J; Tsujii H; Iwakawa M; Imai T
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):685-93. PubMed ID: 17889263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of genome-wide association study-identified genetic variants for colorectal cancer in a Chinese population.
    Xiong F; Wu C; Bi X; Yu D; Huang L; Xu J; Zhang T; Zhai K; Chang J; Tan W; Cai J; Lin D
    Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1855-61. PubMed ID: 20530476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The human leukocyte antigen region and colorectal cancer risk.
    de Jong MM; Niens M; Nolte IM; te Meerman GJ; van der Graaf WT; Mulder MJ; van der Steege G; Bruinenberg M; Schaapveld M; Sijmons RH; Hofstra RM; de Vries EG; Kleibeuker JH
    Dis Colon Rectum; 2005 Feb; 48(2):303-6. PubMed ID: 15714243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased risk of colorectal adenomas in Italian subjects carrying the p53 PIN3 A2-Pro72 haplotype.
    Perfumo C; Bonelli L; Menichini P; Inga A; Gismondi V; Ciferri E; Percivale P; Bianchi Scarrà G; Nasti S; Fronza G; Varesco L
    Digestion; 2006; 74(3-4):228-35. PubMed ID: 17374954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies.
    Johnatty SE; Spurdle AB; Beesley J; Chen X; Hopper JL; Duffy DL; Chenevix-Trench G;
    Breast Cancer Res Treat; 2008 May; 109(1):91-9. PubMed ID: 17592773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a protective haplogenotype within CAPN10 gene influencing colorectal cancer susceptibility.
    Frances CP; Conde MC; Saez ME; Diez SF; Rey CM; Ramírez-Armengol JA; Pascual MH; Gonzalez-Perez A; Torres PP; Real LM; Serrano-Rios M; López JL; Ruiz A; Royo JL
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2298-302. PubMed ID: 17559371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer.
    Yang H; Dinney CP; Ye Y; Zhu Y; Grossman HB; Wu X
    Cancer Res; 2008 Apr; 68(7):2530-7. PubMed ID: 18381463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A systematic assessment of common genetic variation in CYP11A and risk of breast cancer.
    Setiawan VW; Cheng I; Stram DO; Giorgi E; Pike MC; Van Den Berg D; Pooler L; Burtt NP; Le Marchand L; Altshuler D; Hirschhorn J; Henderson BE; Haiman CA
    Cancer Res; 2006 Dec; 66(24):12019-25. PubMed ID: 17178901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of candidate genes carrying polymorphisms associated with the risk of colorectal cancer by analyzing the colorectal mutome and microRNAome.
    Landi D; Gemignani F; Pardini B; Naccarati A; Garritano S; Vodicka P; Vodickova L; Canzian F; Novotny J; Barale R; Landi S
    Cancer; 2012 Oct; 118(19):4670-80. PubMed ID: 22282400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer.
    Landi D; Gemignani F; Naccarati A; Pardini B; Vodicka P; Vodickova L; Novotny J; Försti A; Hemminki K; Canzian F; Landi S
    Carcinogenesis; 2008 Mar; 29(3):579-84. PubMed ID: 18192692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ARLTS1 variants and risk of colorectal cancer.
    Frank B; Hemminki K; Brenner H; Hoffmeister M; Chang-Claude J; Burwinkel B
    Cancer Lett; 2006 Dec; 244(2):172-5. PubMed ID: 16488076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colorectal adenoma risk is modified by the interplay between polymorphisms in arachidonic acid pathway genes and fish consumption.
    Siezen CL; van Leeuwen AI; Kram NR; Luken ME; van Kranen HJ; Kampman E
    Carcinogenesis; 2005 Feb; 26(2):449-57. PubMed ID: 15550453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin pathway related genes and risk of colorectal cancer: INSR promoter polymorphism shows a protective effect.
    Pechlivanis S; Pardini B; Bermejo JL; Wagner K; Naccarati A; Vodickova L; Novotny J; Hemminki K; Vodicka P; Försti A
    Endocr Relat Cancer; 2007 Sep; 14(3):733-40. PubMed ID: 17914103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MHC Class II alleles in ulcerative colitis-associated colorectal cancer.
    Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
    Gut; 2009 Sep; 58(9):1226-33. PubMed ID: 19251712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic variants in selenoprotein genes increase risk of colorectal cancer.
    Méplan C; Hughes DJ; Pardini B; Naccarati A; Soucek P; Vodickova L; Hlavatá I; Vrána D; Vodicka P; Hesketh JE
    Carcinogenesis; 2010 Jun; 31(6):1074-9. PubMed ID: 20378690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphisms of the dopamine receptor gene DRD2 and colorectal cancer risk.
    Gemignani F; Landi S; Moreno V; Gioia-Patricola L; Chabrier A; Guino E; Navarro M; Cambray M; Capellà G; Canzian F
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1633-8. PubMed ID: 16030094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers.
    Ruivenkamp CA; van Wezel T; Zanon C; Stassen AP; Vlcek C; Csikós T; Klous AM; Tripodis N; Perrakis A; Boerrigter L; Groot PC; Lindeman J; Mooi WJ; Meijjer GA; Scholten G; Dauwerse H; Paces V; van Zandwijk N; van Ommen GJ; Demant P
    Nat Genet; 2002 Jul; 31(3):295-300. PubMed ID: 12089527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FOXP3 germline polymorphisms are not associated with risk of breast cancer.
    Raskin L; Rennert G; Gruber SB
    Cancer Genet Cytogenet; 2009 Apr; 190(1):40-2. PubMed ID: 19264232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic analysis of caveolin-1 and eNOS genes in colorectal cancer.
    Conde MC; Ramirez-Lorca R; Lopez-Jamar JM; Molero E; Ramírez-Armengol JA; Moreno Nogueira JA; Pascual MH; Ruiz A; Martín-Cordova CG; Real LM; Royo JL
    Oncol Rep; 2006 Aug; 16(2):353-9. PubMed ID: 16820915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.